| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | NEBL ABI3BP SYNE1 SPTA1 SPTAN1 ACTN2 NEB POF1B SPTBN4 XIRP2 PICK1 | 3.64e-06 | 227 | 168 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NUSAP1 ANK1 NEBL OFD1 ABI3BP CAMK2B SYNE1 SPTA1 SPTAN1 ACTN2 NEB POF1B NME8 KRIT1 PRUNE1 SPTBN4 NF1 XIRP2 DLG1 DLG4 DMD PACSIN2 PICK1 | 5.00e-05 | 1099 | 168 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | hemoglobin beta binding | 7.04e-05 | 2 | 168 | 2 | GO:0031722 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.17e-04 | 130 | 168 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | actin binding | NEBL ABI3BP CAMK2B SYNE1 SPTA1 SPTAN1 ACTN2 NEB POF1B SPTBN4 XIRP2 DMD PICK1 | 2.15e-04 | 479 | 168 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | DCAF1 CAMK2B CAMK2G PIK3R3 TEX14 LCK TEK PTK2B GRK3 IKBKE PIK3R1 PRIM1 DLG1 KDR POLN TNKS2 PPIP5K2 HCK DCLK1 | 3.56e-04 | 938 | 168 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 4.62e-04 | 43 | 168 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 6.00e-04 | 20 | 168 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | hemoglobin alpha binding | 6.92e-04 | 5 | 168 | 2 | GO:0031721 | |
| GeneOntologyMolecularFunction | kinase activity | DCAF1 CAMK2B CAMK2G PIK3R3 TEX14 LCK TEK PTK2B GRK3 IKBKE PIK3R1 DLG1 KDR PPIP5K2 HCK DCLK1 | 7.43e-04 | 764 | 168 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 8.88e-04 | 51 | 168 | 4 | GO:0001784 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | SPTA1 SPTAN1 ACTN2 SPECC1L SPTBN4 PTK2B RHPN2 XIRP2 PIK3R1 RHPN2P1 DLG1 HCK PICK1 NCKAP1L | 1.90e-07 | 300 | 169 | 14 | GO:0110053 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | SPTA1 SPTAN1 ACTN2 SPECC1L NEB SPTBN4 PTK2B RHPN2 XIRP2 PIK3R1 RHPN2P1 DLG1 HCK PICK1 NCKAP1L | 6.68e-07 | 384 | 169 | 15 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | SPTA1 SPTAN1 ACTN2 SPECC1L NEB SPTBN4 PTK2B AKAP9 RHPN2 XIRP2 PIK3R1 RHPN2P1 DLG1 HCK PICK1 NCKAP1L | 6.80e-07 | 438 | 169 | 16 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SPTA1 SPTAN1 ACTN2 SPECC1L PRUNE1 SPTBN4 PTK2B AKAP9 RHPN2 XIRP2 PIK3R1 RHPN2P1 DLG1 HCK PICK1 NCKAP1L | 6.80e-07 | 438 | 169 | 16 | GO:1902903 |
| GeneOntologyBiologicalProcess | actin filament organization | NEBL SPTA1 SPTAN1 ACTN2 SPECC1L NEB POF1B SPTBN4 PTK2B RHPN2 XIRP2 PIK3R1 RHPN2P1 DLG1 HCK PICK1 NCKAP1L | 1.03e-06 | 509 | 169 | 17 | GO:0007015 |
| GeneOntologyBiologicalProcess | actin filament-based process | DOCK2 NEBL ABI3BP SPTA1 SPTAN1 ACTN2 SPECC1L NEB POF1B SPTBN4 PTK2B NF1 AKAP9 RHPN2 XIRP2 PIK3R1 SCN8A RHPN2P1 DLG1 HCK PACSIN2 PICK1 NCKAP1L | 1.62e-06 | 912 | 169 | 23 | GO:0030029 |
| GeneOntologyBiologicalProcess | mating plug formation | 2.15e-06 | 4 | 169 | 3 | GO:0042628 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | SPTA1 SPTAN1 ACTN2 SPECC1L NEB SPTBN4 PTK2B DLG1 HCK NCKAP1L | 2.41e-06 | 180 | 169 | 10 | GO:0030832 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | DOCK2 NEBL ABI3BP SPTA1 SPTAN1 ACTN2 SPECC1L NEB POF1B SPTBN4 PTK2B NF1 RHPN2 XIRP2 PIK3R1 RHPN2P1 DLG1 HCK PACSIN2 PICK1 NCKAP1L | 2.73e-06 | 803 | 169 | 21 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | NUSAP1 ANK1 ABI3BP CAMK2B SYNE1 SPTA1 SPTAN1 SMC4 ACTN2 SPECC1L TEX14 NEB ASAP1 PRUNE1 SPTBN4 PTK2B AKAP9 RHPN2 XIRP2 PIK3R1 RHPN2P1 CCT8 DLG1 KDR TNKS2 HCK PICK1 NCKAP1L | 4.44e-06 | 1342 | 169 | 28 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | SPTA1 SPTAN1 ACTN2 SPECC1L NEB PRUNE1 SPTBN4 PTK2B AKAP9 RHPN2 XIRP2 PIK3R1 RHPN2P1 DLG1 HCK PICK1 NCKAP1L | 5.83e-06 | 579 | 169 | 17 | GO:0051493 |
| GeneOntologyBiologicalProcess | postsynapse organization | ABI3BP CAMK2B RTN4 CC2D1A ASAP1 PTK2B NF1 SRGAP3 DLG1 DLG4 DCLK1 PICK1 | 1.10e-05 | 313 | 169 | 12 | GO:0099173 |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 1.59e-05 | 177 | 169 | 9 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 2.25e-05 | 185 | 169 | 9 | GO:0099175 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | SLC12A6 SPTA1 SPTAN1 RTN4 ACTN2 SPECC1L NEB SPTBN4 PTK2B RPTOR DLG1 HCK NCKAP1L | 5.17e-05 | 426 | 169 | 13 | GO:0032535 |
| GeneOntologyBiologicalProcess | hemopoiesis | DOCK2 DCAF1 TET2 ANK1 RC3H1 SPTA1 PIK3R3 IRF8 SYCP3 LCK HRNR TEK PTK2B CD3G NF1 GPC3 PIK3R1 RPTOR N4BP2L2 KDR HBB HBD PRG4 NCKAP1L | 6.18e-05 | 1223 | 169 | 24 | GO:0030097 |
| GeneOntologyBiologicalProcess | negative regulation of vasculogenesis | 6.67e-05 | 2 | 169 | 2 | GO:2001213 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | RTN4 PIK3R3 XDH SPECC1L TEK PTK2B NF1 PIK3R1 WNT16 DLG1 KDR CNTF | 7.67e-05 | 382 | 169 | 12 | GO:0043491 |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 9.29e-05 | 222 | 169 | 9 | GO:0008154 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | ABI3BP CAMK2B RTN4 CC2D1A ASAP1 PTK2B NF1 SRGAP3 PIK3R1 DLG4 DCLK1 PICK1 | 1.05e-04 | 395 | 169 | 12 | GO:0050803 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABI3BP SYNE1 SPTA1 SPTAN1 RTN4 CC2D1A TEK ASAP1 PRUNE1 SPTBN4 PTK2B AKAP9 RHPN2 IKBKE SRGAP3 PIK3R1 RHPN2P1 DLG1 DLG4 KDR HCK DCLK1 NCKAP1L | 1.10e-04 | 1189 | 169 | 23 | GO:0044087 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | NEBL SPTA1 SPTAN1 ACTN2 SPECC1L NEB POF1B PRUNE1 SPTBN4 PTK2B NF1 AKAP9 RHPN2 XIRP2 PIK3R1 RHPN2P1 DLG1 HCK PICK1 NCKAP1L | 1.16e-04 | 957 | 169 | 20 | GO:0097435 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 1.17e-04 | 93 | 169 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 1.26e-04 | 231 | 169 | 9 | GO:0032271 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DOCK2 NUSAP1 ANK1 ABCA13 CAMK2B SYNE1 SMC4 ACTN2 TEK ASAP1 PTK2B NF1 AKAP9 GPC3 PIK3R1 CCT8 DLG1 DLG4 KDR DMD TNKS2 HCK CNTF PICK1 NCKAP1L | 1.30e-04 | 1366 | 169 | 25 | GO:0051130 |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 1.43e-04 | 61 | 169 | 5 | GO:0030834 | |
| GeneOntologyBiologicalProcess | cell junction organization | ABI3BP CAMK2B RTN4 CC2D1A ACTN2 SPECC1L TEK POF1B ASAP1 SPTBN4 PTK2B NF1 XIRP2 SRGAP3 PIK3R1 DLG1 DLG4 KDR DCLK1 PICK1 | 1.46e-04 | 974 | 169 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | SLC12A6 SPTA1 SPTAN1 RTN4 ACTN2 SPECC1L NEB SPTBN4 PTK2B RPTOR DLG1 KDR HBB HCK NCKAP1L | 1.79e-04 | 618 | 169 | 15 | GO:0090066 |
| GeneOntologyBiologicalProcess | regulation of Rac protein signal transduction | 1.87e-04 | 35 | 169 | 4 | GO:0035020 | |
| GeneOntologyBiologicalProcess | positive regulation of serine-type peptidase activity | 1.99e-04 | 3 | 169 | 2 | GO:1902573 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 1.99e-04 | 3 | 169 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | positive regulation of serine-type endopeptidase activity | 1.99e-04 | 3 | 169 | 2 | GO:1900005 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 2.04e-04 | 194 | 169 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 2.08e-04 | 66 | 169 | 5 | GO:0030042 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 2.26e-04 | 197 | 169 | 8 | GO:1902904 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 2.42e-04 | 309 | 169 | 10 | GO:1901888 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 2.68e-04 | 202 | 169 | 8 | GO:0051963 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.78e-04 | 257 | 169 | 9 | GO:0007163 | |
| GeneOntologyBiologicalProcess | insemination | 2.80e-04 | 16 | 169 | 3 | GO:0007320 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | NUSAP1 ANK1 CAMK2B SMC4 ACTN2 ASAP1 PTK2B AKAP9 CCT8 DLG1 KDR TNKS2 HCK NCKAP1L | 2.81e-04 | 574 | 169 | 14 | GO:0010638 |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 3.06e-04 | 156 | 169 | 7 | GO:0030833 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 3.16e-04 | 40 | 169 | 4 | GO:0048169 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | ABI3BP CAMK2B RTN4 CC2D1A ASAP1 PTK2B NF1 SRGAP3 PIK3R1 DLG4 DCLK1 | 3.61e-04 | 387 | 169 | 11 | GO:0050807 |
| GeneOntologyBiologicalProcess | negative regulation of cilium movement | 3.96e-04 | 4 | 169 | 2 | GO:0003354 | |
| GeneOntologyBiologicalProcess | negative regulation of cilium-dependent cell motility | 3.96e-04 | 4 | 169 | 2 | GO:1902020 | |
| GeneOntologyBiologicalProcess | negative regulation of flagellated sperm motility | 3.96e-04 | 4 | 169 | 2 | GO:1901318 | |
| GeneOntologyBiologicalProcess | regulation of eIF2 alpha phosphorylation by heme | 3.96e-04 | 4 | 169 | 2 | GO:0010999 | |
| GeneOntologyBiologicalProcess | positive regulation of Rac protein signal transduction | 4.03e-04 | 18 | 169 | 3 | GO:0035022 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse assembly | 4.57e-04 | 44 | 169 | 4 | GO:0150052 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 5.43e-04 | 46 | 169 | 4 | GO:0010526 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase III | 5.56e-04 | 20 | 169 | 3 | GO:0045945 | |
| GeneOntologyBiologicalProcess | retrotransposition | 6.39e-04 | 48 | 169 | 4 | GO:0032197 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum tubular network formation | 6.57e-04 | 5 | 169 | 2 | GO:0071787 | |
| GeneOntologyBiologicalProcess | regulation of snRNA transcription by RNA polymerase II | 6.57e-04 | 5 | 169 | 2 | GO:1905380 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine autophosphorylation | 7.42e-04 | 22 | 169 | 3 | GO:0038083 | |
| GeneOntologyBiologicalProcess | transposition | 7.47e-04 | 50 | 169 | 4 | GO:0032196 | |
| GeneOntologyBiologicalProcess | cell junction assembly | ABI3BP RTN4 CC2D1A ACTN2 TEK POF1B PTK2B SRGAP3 PIK3R1 DLG1 DLG4 KDR DCLK1 | 8.51e-04 | 569 | 169 | 13 | GO:0034329 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 8.67e-04 | 52 | 169 | 4 | GO:0030835 | |
| GeneOntologyCellularComponent | postsynaptic specialization | ABI3BP CAMK2B CAMK2G RTN4 ACTN2 LCK ERBIN RTN1 FAM81A PTK2B GRK3 AKAP9 SCN8A DLG1 DLG4 EIF3A DMD DCLK1 PICK1 | 2.50e-08 | 503 | 168 | 19 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | ABI3BP CAMK2B CAMK2G RTN4 ACTN2 RTN1 FAM81A PTK2B GRK3 AKAP9 SCN8A DLG1 DLG4 EIF3A DMD DCLK1 PICK1 | 1.46e-07 | 451 | 168 | 17 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | ABI3BP CAMK2B CAMK2G RTN4 ACTN2 RTN1 FAM81A PTK2B GRK3 AKAP9 SCN8A DLG1 DLG4 EIF3A DMD DCLK1 PICK1 | 3.23e-07 | 477 | 168 | 17 | GO:0032279 |
| GeneOntologyCellularComponent | postsynapse | ANK1 ABI3BP CAMK2B SYNE1 CAMK2G SPTAN1 RTN4 LAMA2 ACTN2 LCK ERBIN RTN1 FAM81A ASAP1 PTK2B GRK3 AKAP9 SRGAP3 SCN8A DLG1 DLG4 EIF3A DMD DCLK1 PICK1 | 6.20e-07 | 1018 | 168 | 25 | GO:0098794 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ABI3BP CAMK2B CAMK2G RTN4 ACTN2 RTN1 FAM81A PTK2B GRK3 AKAP9 SCN8A DLG1 DLG4 EIF3A DMD DCLK1 PICK1 | 1.15e-06 | 523 | 168 | 17 | GO:0098984 |
| GeneOntologyCellularComponent | Z disc | 3.75e-06 | 151 | 168 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 8.12e-06 | 166 | 168 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CAMK2B SPTAN1 RTN4 CC2D1A ACTN2 LCK ERBIN FAM81A ASAP1 PTK2B NF1 GRK3 AKAP9 SRGAP3 SCN8A DLG1 DLG4 DCLK1 PACSIN2 PICK1 | 9.57e-06 | 817 | 168 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | anchoring junction | SPTAN1 RTN4 ACTN2 SPECC1L LCK TEK ERBIN POF1B KRIT1 PRUNE1 SPTBN4 PTK2B GJB3 UBA1 XIRP2 PIK3R1 DLG1 DLG4 KDR DMD HCK PACSIN2 | 1.22e-05 | 976 | 168 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | sarcomere | 3.48e-05 | 249 | 168 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | spectrin | 4.13e-05 | 9 | 168 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | somatodendritic compartment | BRINP3 ABI3BP CAMK2B SYNE1 RTN4 NAIP LAMA2 ACTN2 RTN1 ASAP1 SPTBN4 PTK2B NF1 GRK3 AKAP9 RPTOR SCN8A DLG1 DLG4 KDR RBM8A DMD CNTF PICK1 | 4.85e-05 | 1228 | 168 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | myofibril | 7.53e-05 | 273 | 168 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | main axon | 8.25e-05 | 89 | 168 | 6 | GO:0044304 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 8.66e-05 | 56 | 168 | 5 | GO:0099091 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.24e-04 | 290 | 168 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | dendritic spine | 1.54e-04 | 242 | 168 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.80e-04 | 247 | 168 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | dendrite | BRINP3 ABI3BP CAMK2B SYNE1 LAMA2 ACTN2 RTN1 ASAP1 PTK2B NF1 GRK3 AKAP9 RPTOR SCN8A DLG1 DLG4 RBM8A PICK1 | 1.95e-04 | 858 | 168 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | BRINP3 ABI3BP CAMK2B SYNE1 LAMA2 ACTN2 RTN1 ASAP1 PTK2B NF1 GRK3 AKAP9 RPTOR SCN8A DLG1 DLG4 RBM8A PICK1 | 2.00e-04 | 860 | 168 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | paranode region of axon | 3.19e-04 | 17 | 168 | 3 | GO:0033270 | |
| GeneOntologyCellularComponent | node of Ranvier | 5.26e-04 | 20 | 168 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 6.21e-04 | 129 | 168 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 6.32e-04 | 5 | 168 | 2 | GO:0005954 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 6.43e-04 | 49 | 168 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 7.23e-04 | 88 | 168 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | actin cytoskeleton | NEBL SPTA1 SPTAN1 ACTN2 SPECC1L NEB TEK POF1B ASAP1 SPTBN4 XIRP2 H1-0 HCK | 7.97e-04 | 576 | 168 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | cell-cell junction | SPTAN1 SPECC1L LCK TEK POF1B KRIT1 SPTBN4 GJB3 UBA1 PIK3R1 DLG1 DLG4 PACSIN2 | 1.01e-03 | 591 | 168 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | actin filament | 1.18e-03 | 146 | 168 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | dendritic branch | 1.31e-03 | 7 | 168 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | pericentriolar material | 1.44e-03 | 28 | 168 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.71e-03 | 157 | 168 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 2.23e-03 | 9 | 168 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.23e-03 | 9 | 168 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 2.23e-03 | 9 | 168 | 2 | GO:0005943 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.29e-03 | 114 | 168 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | supramolecular fiber | NUSAP1 ANK1 NEBL SYNE1 SPTAN1 ACTN2 SPECC1L NEB TEK POF1B SPTBN4 GRK3 XIRP2 SCN8A CCT8 DLG1 EIF3A DMD HCK | 3.02e-03 | 1179 | 168 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | microtubule organizing center | SPATA7 TRAF5 OFD1 CAMK2B CC2D1A SPECC1L LCK TEK USP20 MYOF AKAP9 CCT8 TNKS2 EXOC7 ZBED1 PACSIN2 | 3.07e-03 | 919 | 168 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | neuronal cell body | BRINP3 CAMK2B RTN4 NAIP RTN1 SPTBN4 PTK2B AKAP9 RPTOR SCN8A DLG1 KDR RBM8A DMD CNTF | 3.08e-03 | 835 | 168 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | supramolecular polymer | NUSAP1 ANK1 NEBL SYNE1 SPTAN1 ACTN2 SPECC1L NEB TEK POF1B SPTBN4 GRK3 XIRP2 SCN8A CCT8 DLG1 EIF3A DMD HCK | 3.26e-03 | 1187 | 168 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | cell body | BRINP3 CAMK2B RTN4 NAIP RTN1 SPTBN4 PTK2B AKAP9 RPTOR SCN8A CCT8 DLG1 KDR RBM8A DMD CNTF | 3.41e-03 | 929 | 168 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | centriolar satellite | 3.78e-03 | 128 | 168 | 5 | GO:0034451 | |
| GeneOntologyCellularComponent | centrosome | TRAF5 OFD1 CAMK2B CC2D1A LCK TEK USP20 MYOF AKAP9 CCT8 TNKS2 EXOC7 ZBED1 PACSIN2 | 3.79e-03 | 770 | 168 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 3.88e-03 | 185 | 168 | 6 | GO:0009898 | |
| GeneOntologyCellularComponent | haptoglobin-hemoglobin complex | 4.02e-03 | 12 | 168 | 2 | GO:0031838 | |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 4.02e-03 | 12 | 168 | 2 | GO:0044224 | |
| GeneOntologyCellularComponent | hemoglobin complex | 4.02e-03 | 12 | 168 | 2 | GO:0005833 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.44e-03 | 320 | 168 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | cuticular plate | 4.73e-03 | 13 | 168 | 2 | GO:0032437 | |
| Domain | SH3_domain | DOCK2 NEBL SPTA1 SPTAN1 LCK NEB ASAP1 MIA2 SRGAP3 PIK3R1 DLG1 DLG4 HCK PACSIN2 | 9.85e-09 | 220 | 165 | 14 | IPR001452 |
| Domain | SH3_1 | NEBL SPTA1 SPTAN1 LCK NEB ASAP1 SRGAP3 PIK3R1 DLG1 DLG4 HCK PACSIN2 | 2.48e-08 | 164 | 165 | 12 | PF00018 |
| Domain | Spectrin | 3.87e-08 | 23 | 165 | 6 | PF00435 | |
| Domain | SH3 | DOCK2 NEBL SPTA1 SPTAN1 LCK NEB ASAP1 SRGAP3 PIK3R1 DLG1 DLG4 HCK PACSIN2 | 6.54e-08 | 216 | 165 | 13 | SM00326 |
| Domain | SH3 | DOCK2 NEBL SPTA1 SPTAN1 LCK NEB ASAP1 SRGAP3 PIK3R1 DLG1 DLG4 HCK PACSIN2 | 6.54e-08 | 216 | 165 | 13 | PS50002 |
| Domain | Spectrin_repeat | 1.74e-07 | 29 | 165 | 6 | IPR002017 | |
| Domain | SPEC | 3.25e-07 | 32 | 165 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.25e-07 | 32 | 165 | 6 | IPR018159 | |
| Domain | EFhand_Ca_insen | 1.33e-05 | 6 | 165 | 3 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.33e-05 | 6 | 165 | 3 | IPR014837 | |
| Domain | ACTININ_2 | 4.56e-05 | 23 | 165 | 4 | PS00020 | |
| Domain | ACTININ_1 | 4.56e-05 | 23 | 165 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.56e-05 | 23 | 165 | 4 | IPR001589 | |
| Domain | Semenogelin | 7.76e-05 | 2 | 165 | 2 | PF05474 | |
| Domain | Semenogelin | 7.76e-05 | 2 | 165 | 2 | IPR008836 | |
| Domain | PI3K_P85_iSH2 | 2.31e-04 | 3 | 165 | 2 | IPR032498 | |
| Domain | PI3K_P85_iSH2 | 2.31e-04 | 3 | 165 | 2 | PF16454 | |
| Domain | CH | 2.73e-04 | 65 | 165 | 5 | SM00033 | |
| Domain | Spectrin_alpha_SH3 | 2.85e-04 | 15 | 165 | 3 | IPR013315 | |
| Domain | CH | 3.86e-04 | 70 | 165 | 5 | PF00307 | |
| Domain | - | 4.12e-04 | 71 | 165 | 5 | 1.10.418.10 | |
| Domain | Nebulin | 4.60e-04 | 4 | 165 | 2 | PF00880 | |
| Domain | CaMKII_AD | 4.60e-04 | 4 | 165 | 2 | PF08332 | |
| Domain | MAGUK_N_PEST | 4.60e-04 | 4 | 165 | 2 | PF10608 | |
| Domain | PDZ_assoc | 4.60e-04 | 4 | 165 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 4.60e-04 | 4 | 165 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 4.60e-04 | 4 | 165 | 2 | IPR019583 | |
| Domain | NEBULIN | 4.60e-04 | 4 | 165 | 2 | PS51216 | |
| Domain | MAGUK_N_PEST | 4.60e-04 | 4 | 165 | 2 | SM01277 | |
| Domain | DLG1 | 4.60e-04 | 4 | 165 | 2 | IPR016313 | |
| Domain | COE | 4.60e-04 | 4 | 165 | 2 | PS01345 | |
| Domain | NEBU | 4.60e-04 | 4 | 165 | 2 | SM00227 | |
| Domain | Transcription_factor_COE | 4.60e-04 | 4 | 165 | 2 | IPR003523 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 4.60e-04 | 4 | 165 | 2 | IPR013543 | |
| Domain | Nebulin | 4.60e-04 | 4 | 165 | 2 | IPR013998 | |
| Domain | COE_HLH | 4.60e-04 | 4 | 165 | 2 | IPR032201 | |
| Domain | COE_DBD | 4.60e-04 | 4 | 165 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 4.60e-04 | 4 | 165 | 2 | IPR018350 | |
| Domain | COE1_HLH | 4.60e-04 | 4 | 165 | 2 | PF16423 | |
| Domain | COE1_DBD | 4.60e-04 | 4 | 165 | 2 | PF16422 | |
| Domain | Nebulin_repeat | 4.60e-04 | 4 | 165 | 2 | IPR000900 | |
| Domain | CH | 4.69e-04 | 73 | 165 | 5 | PS50021 | |
| Domain | zf-C2H2_6 | PEG3 ZNF267 ZNF883 ZNF676 ZNF587 ZNF408 ZNF737 ZNF721 ZNF417 ZNF726 | 4.92e-04 | 314 | 165 | 10 | PF13912 |
| Domain | CH-domain | 5.31e-04 | 75 | 165 | 5 | IPR001715 | |
| Domain | FerI | 7.62e-04 | 5 | 165 | 2 | SM01202 | |
| Domain | FerB | 7.62e-04 | 5 | 165 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 7.62e-04 | 5 | 165 | 2 | IPR012561 | |
| Domain | Ferlin_C | 7.62e-04 | 5 | 165 | 2 | PF16165 | |
| Domain | Ferlin_C | 7.62e-04 | 5 | 165 | 2 | IPR032362 | |
| Domain | FerIin_dom | 7.62e-04 | 5 | 165 | 2 | IPR012968 | |
| Domain | SMC | 7.62e-04 | 5 | 165 | 2 | IPR024704 | |
| Domain | FerI | 7.62e-04 | 5 | 165 | 2 | PF08151 | |
| Domain | FerB | 7.62e-04 | 5 | 165 | 2 | PF08150 | |
| Domain | Haemoglobin_b | 7.62e-04 | 5 | 165 | 2 | IPR002337 | |
| Domain | PI3kinase_P85 | 7.62e-04 | 5 | 165 | 2 | IPR001720 | |
| Domain | RETICULON | 7.62e-04 | 5 | 165 | 2 | PS50845 | |
| Domain | Pkinase_Tyr | 1.01e-03 | 129 | 165 | 6 | PF07714 | |
| Domain | Tyr_kinase_cat_dom | 1.10e-03 | 88 | 165 | 5 | IPR020635 | |
| Domain | TyrKc | 1.10e-03 | 88 | 165 | 5 | SM00219 | |
| Domain | SMC_hinge | 1.14e-03 | 6 | 165 | 2 | SM00968 | |
| Domain | SMC_hinge | 1.14e-03 | 6 | 165 | 2 | PF06470 | |
| Domain | SMC_hinge | 1.14e-03 | 6 | 165 | 2 | IPR010935 | |
| Domain | TPR_8 | 1.23e-03 | 53 | 165 | 4 | PF13181 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.43e-03 | 138 | 165 | 6 | IPR001245 | |
| Domain | Reticulon | 1.58e-03 | 7 | 165 | 2 | PF02453 | |
| Domain | PROTEIN_KINASE_TYR | 1.70e-03 | 97 | 165 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.70e-03 | 97 | 165 | 5 | IPR008266 | |
| Domain | ANK_REPEAT | 1.88e-03 | 253 | 165 | 8 | PS50088 | |
| Domain | ANK_REP_REGION | 1.92e-03 | 254 | 165 | 8 | PS50297 | |
| Domain | Protein_kinase_ATP_BS | 2.03e-03 | 379 | 165 | 10 | IPR017441 | |
| Domain | HATC_C_dom | 2.10e-03 | 8 | 165 | 2 | IPR008906 | |
| Domain | Dimer_Tnp_hAT | 2.10e-03 | 8 | 165 | 2 | PF05699 | |
| Domain | RecF/RecN/SMC_N | 2.10e-03 | 8 | 165 | 2 | IPR003395 | |
| Domain | SMC_N | 2.10e-03 | 8 | 165 | 2 | PF02463 | |
| Domain | Reticulon | 2.10e-03 | 8 | 165 | 2 | IPR003388 | |
| Domain | Kinase-like_dom | CAMK2B CAMK2G TEX14 LCK TEK PTK2B GRK3 IKBKE KDR DMD HCK DCLK1 | 3.21e-03 | 542 | 165 | 12 | IPR011009 |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 8.90e-07 | 20 | 131 | 5 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.16e-06 | 21 | 131 | 5 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.16e-06 | 21 | 131 | 5 | M27944 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.43e-06 | 10 | 131 | 4 | MM15112 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.49e-06 | 22 | 131 | 5 | MM15104 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.89e-06 | 23 | 131 | 5 | M27949 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 5.31e-06 | 28 | 131 | 5 | M837 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 6.37e-06 | 29 | 131 | 5 | MM15028 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 6.52e-06 | 50 | 131 | 6 | M39822 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.98e-06 | 31 | 131 | 5 | M877 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 8.98e-06 | 31 | 131 | 5 | M7223 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.67e-05 | 35 | 131 | 5 | MM15109 | |
| Pathway | BIOCARTA_PDZS_PATHWAY | 1.97e-05 | 18 | 131 | 4 | M22001 | |
| Pathway | REACTOME_NRCAM_INTERACTIONS | 2.67e-05 | 7 | 131 | 3 | M27378 | |
| Pathway | REACTOME_NEF_AND_SIGNAL_TRANSDUCTION | 4.24e-05 | 8 | 131 | 3 | M26997 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 5.21e-05 | 44 | 131 | 5 | M27934 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 7.20e-05 | 47 | 131 | 5 | M39531 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.34e-04 | 121 | 131 | 7 | M872 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | CAMK2B CAMK2G SPTA1 SPTAN1 ACTN2 TEK SPTBN4 NF1 PIK3R1 DLG1 DLG4 | 1.85e-04 | 318 | 131 | 11 | MM15278 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | CAMK2B CAMK2G SPTA1 SPTAN1 ACTN2 TEK SPTBN4 NF1 PIK3R1 DLG1 DLG4 | 2.36e-04 | 327 | 131 | 11 | M27565 |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 2.98e-04 | 35 | 131 | 4 | MM15144 | |
| Pathway | PID_CXCR4_PATHWAY | 3.35e-04 | 100 | 131 | 6 | M124 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 4.02e-04 | 16 | 131 | 3 | MM1512 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 4.02e-04 | 16 | 131 | 3 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 4.02e-04 | 16 | 131 | 3 | MM1420 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 5.02e-04 | 40 | 131 | 4 | M39695 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 7.25e-04 | 44 | 131 | 4 | M1012 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 7.96e-04 | 20 | 131 | 3 | M39002 | |
| Pubmed | SLC12A6 CAMK2B SYNE1 CAMK2G SPTA1 TTC21A SPTAN1 RTN4 ACTN2 SPECC1L PLEKHA6 ERBIN RTN1 ASAP1 SPTBN4 CSDE1 PTK2B UBA1 CSE1L NF1 SRGAP3 RPTOR H1-0 FTH1 OSBPL10 CCT8 DLG1 DLG4 STIP1 EIF3A DMD HBB HBD HCK DCLK1 | 2.12e-15 | 1431 | 169 | 35 | 37142655 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | CAMK2B SYNE1 CAMK2G SPTAN1 CHCHD6 SPECC1L FAM81A ASAP1 PTK2B NF1 GRK3 SRGAP3 DLG1 DLG4 STIP1 DCLK1 | 7.24e-13 | 281 | 169 | 16 | 28706196 |
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 1.45e-11 | 86 | 169 | 10 | 10862698 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | SLC12A6 ANK1 CAMK2B CAMK2G SPTA1 SPTAN1 NAIP MCCC1 ASAP1 PTK2B SRGAP3 CCT8 DLG4 EIF3A HBB HBD HCK DCLK1 PACSIN2 | 2.37e-10 | 621 | 169 | 19 | 22794259 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAF1 SPATA7 ZNF143 OFD1 EBF3 CAMK2B SMC1A TTC21A SMC4 CCDC150 CHCHD6 NME8 TAF6L UBA1 PTPN14 CSE1L NF1 PTPRG GID4 PIK3R1 RPTOR XPNPEP3 EIF5B PPIP5K2 EXOC7 DCLK1 | 1.38e-09 | 1321 | 169 | 26 | 27173435 |
| Pubmed | CAMK2B CAMK2G SPTAN1 RTN4 ACTN2 RTN1 UBA1 H1-0 CCT8 DLG1 DLG4 STIP1 HBB HBD DCLK1 | 1.47e-09 | 403 | 169 | 15 | 30562941 | |
| Pubmed | SLC12A6 ABI3BP CAMK2B SYNE1 CAMK2G SPTA1 SPTAN1 UGGT1 SMC4 CCDC150 ACTN2 TEX14 NEB ERBIN ERLEC1 SPTBN4 ATP6V1G3 MIA2 H1-0 EIF5B DLG1 KDR EIF3A DMD PPIP5K2 PICK1 DNMT3B | 1.87e-09 | 1442 | 169 | 27 | 35575683 | |
| Pubmed | ABI3BP SYNE1 SPTAN1 SPECC1L PLEKHA6 NEB ERBIN ASAP1 CSDE1 CSE1L PIK3R1 FTH1 EIF3A DMD HCK PACSIN2 | 2.38e-09 | 486 | 169 | 16 | 20936779 | |
| Pubmed | SLC12A6 SYNE1 SMC1A PEG3 LAMA2 ACTN2 NEB ASAP1 AKAP9 GPC3 XIRP2 FTH1 STIP1 EIF3A TNKS2 ZNF417 | 3.27e-09 | 497 | 169 | 16 | 23414517 | |
| Pubmed | DOCK2 CALU CAMK2G SMC1A UGGT1 SMC4 MCCC1 ASAP1 CSDE1 UBA1 CSE1L SRGAP3 PIK3R1 DLG1 STIP1 DMD TNKS2 PPIP5K2 HBB PLOD1 PACSIN2 | 4.50e-09 | 916 | 169 | 21 | 32203420 | |
| Pubmed | NUSAP1 SOX5 TET2 NOL4 ZNF143 OFD1 CALU TNPO2 RC3H1 SMC1A SPTAN1 IRF8 CC2D1A MCCC1 HRNR ERBIN TAF6L CSE1L FTH1 EHMT1 SCAF11 ZNF721 STIP1 EIF3A ZMYM1 PACSIN2 | 6.98e-09 | 1429 | 169 | 26 | 35140242 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 8.04e-09 | 120 | 169 | 9 | 31413325 | |
| Pubmed | EBF3 CAMK2B SYNE1 CAMK2G SPTAN1 SPECC1L ERBIN RTN1 FAM81A SPTBN4 UBA1 NF1 AKAP9 SRGAP3 RPTOR EHMT1 CCT8 DLG1 DLG4 STIP1 DCLK1 | 1.07e-08 | 963 | 169 | 21 | 28671696 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NUSAP1 ERCC6 CAMK2G SMC1A SPTAN1 UGGT1 SMC4 SPECC1L HRNR CSDE1 MYOF UBA1 PTPN14 CSE1L PRIM1 H1-0 EIF5B CCT8 DLG1 SCAF11 RBM8A EIF3A HBD AQR | 1.14e-08 | 1257 | 169 | 24 | 36526897 |
| Pubmed | SEMG1 DPP10 CALU SYNE1 SMC1A SMC4 GBE1 IFIT1 MYOF UBA1 CSE1L NF1 H1-0 CCT8 STIP1 EIF3A HBB PLOD1 DCLK1 | 1.56e-08 | 803 | 169 | 19 | 36517590 | |
| Pubmed | CAMK2B SYNE1 CAMK2G SPTAN1 ERBIN FAM81A SPTBN4 UBA1 DLG1 DLG4 DCLK1 | 4.70e-08 | 251 | 169 | 11 | 27507650 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 SEMG1 SMC1A RTN4 UGGT1 SMC4 CC2D1A POF1B ERLEC1 PRUNE1 PTPN14 CSE1L CCT8 TMEM192 DLG1 DLG4 STIP1 EIF3A DMD PLOD1 | 6.56e-08 | 974 | 169 | 20 | 28675297 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 SYNE1 SPTA1 SPTAN1 RTN4 UGGT1 MCCC1 MYOF CSE1L AKAP9 H1-0 SCN8A EIF5B CCT8 RBM8A STIP1 EIF3A HBB | 9.25e-08 | 807 | 169 | 18 | 30575818 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CAMK2G RC3H1 SPTAN1 RTN4 CC2D1A SPECC1L MCCC1 CSDE1 MYOF UBA1 EHMT1 EIF5B CCT8 ZMYM1 HBB HBD PLOD1 | 1.04e-07 | 724 | 169 | 17 | 36232890 |
| Pubmed | Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. | 1.13e-07 | 3 | 169 | 3 | 2971657 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | SPTAN1 UGGT1 SMC4 GBE1 XDH MYOF UBA1 CSE1L EIF5B CCT8 EIF3A NCKAP1L | 1.37e-07 | 344 | 169 | 12 | 30333137 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | OFD1 SYNE1 SMC1A UGGT1 SMC4 SPECC1L HRNR TAF6L UBA1 CSE1L NF1 XPNPEP3 H1-0 EIF5B CCT8 RBM8A STIP1 EIF3A PLOD1 AQR | 1.46e-07 | 1024 | 169 | 20 | 24711643 |
| Pubmed | CAMK2B CAMK2G SPTAN1 RTN4 NAIP PLEKHA6 RTN1 NF1 SRGAP3 RPTOR DLG4 DCLK1 | 1.51e-07 | 347 | 169 | 12 | 17114649 | |
| Pubmed | CAMK2B CAMK2G SPTAN1 RTN4 MCCC1 ERBIN RTN1 ASAP1 PRUNE1 CSDE1 UBA1 CSE1L NF1 SRGAP3 RPTOR H1-0 CCT8 DLG1 DLG4 STIP1 DCLK1 | 1.81e-07 | 1139 | 169 | 21 | 36417873 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 ERCC6 CAMK2G SMC1A SPTAN1 SMC4 CHCHD6 MCCC1 ERBIN ASAP1 CSDE1 UBA1 PTPN14 CSE1L NF1 RPTOR H1-0 EIF5B CCT8 RBM8A EIF3A PLOD1 AQR | 1.90e-07 | 1353 | 169 | 23 | 29467282 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 OFD1 CALU SPTAN1 CC2D1A MCCC1 LCK ERBIN PTK2B PTPN14 NF1 AKAP9 IKBKE RPTOR OSBPL10 PPIP5K2 DCLK1 AQR | 2.40e-07 | 861 | 169 | 18 | 36931259 |
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 8665664 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 12815021 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 8615909 | ||
| Pubmed | 3.20e-07 | 56 | 169 | 6 | 22745667 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 22378846 | ||
| Pubmed | Lano, a novel LAP protein directly connected to MAGUK proteins in epithelial cells. | 4.49e-07 | 4 | 169 | 3 | 11440998 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 23985323 | ||
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 10373510 | ||
| Pubmed | CALU TNPO2 SPTAN1 RTN4 UGGT1 SMC4 GBE1 SPECC1L MCCC1 ERBIN IFIT1 ERLEC1 CSDE1 MYOF CSE1L GID4 H1-0 EIF5B CCT8 STIP1 EIF3A EXOC7 PLOD1 | 5.62e-07 | 1440 | 169 | 23 | 30833792 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ANK1 TNPO2 TTC21A LCA5L SMC4 HRNR ERLEC1 USP20 TAF6L SRGAP3 ZNF408 SCN8A CCT8 STIP1 EIF3A PRG4 | 6.97e-07 | 736 | 169 | 16 | 29676528 |
| Pubmed | 7.04e-07 | 15 | 169 | 4 | 9481670 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 7.04e-07 | 15 | 169 | 4 | 14622581 | |
| Pubmed | NEBL CALU SMC1A SPTAN1 RTN4 SMC4 SPECC1L PLEKHA6 ERBIN MYOF PTPN14 CSE1L AKAP9 PIK3R1 H1-0 EIF5B CCT8 DLG1 RBM8A STIP1 AQR | 7.89e-07 | 1247 | 169 | 21 | 27684187 | |
| Pubmed | NUSAP1 OFD1 CALU SPTAN1 UGGT1 PIK3R3 ERBIN ASAP1 UBA1 PTPN14 CSE1L AKAP9 PTPRG PIK3R1 PRIM1 DLG1 STIP1 DMD PLOD1 | 9.48e-07 | 1049 | 169 | 19 | 27880917 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 NUSAP1 CALU SYNE1 SMC1A XDH CHCHD6 MAU2 LCK POF1B CSDE1 UBA1 PER3 NUP37 FTH1 EHMT1 EIF3A ZMYM1 PLOD1 AQR | 9.63e-07 | 1155 | 169 | 20 | 20360068 |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 21406181 | ||
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 27137933 | ||
| Pubmed | SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism. | 1.12e-06 | 5 | 169 | 3 | 12860415 | |
| Pubmed | CAMK2B SPTA1 MCCC1 ERBIN NF1 SRGAP3 RPTOR XPNPEP3 DLG1 DLG4 HBB HBD | 1.45e-06 | 430 | 169 | 12 | 32581705 | |
| Pubmed | Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. | 1.56e-06 | 18 | 169 | 4 | 12093914 | |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 1.56e-06 | 18 | 169 | 4 | 18311135 | |
| Pubmed | 2.64e-06 | 304 | 169 | 10 | 32235678 | ||
| Pubmed | DCAF1 CALU RTN4 UGGT1 ERLEC1 CSDE1 PTK2B UBA1 AKAP9 TMEM192 EIF3A PLOD1 | 2.72e-06 | 457 | 169 | 12 | 22190034 | |
| Pubmed | 3.15e-06 | 181 | 169 | 8 | 37372979 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 3.62e-06 | 315 | 169 | 10 | 26777405 | |
| Pubmed | EG-1 interacts with c-Src and activates its signaling pathway. | 3.68e-06 | 22 | 169 | 4 | 16964398 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | CALU SPTAN1 UGGT1 SMC4 ACTN2 SPECC1L HRNR POF1B UBA1 XPNPEP3 FTH1 CCT8 EIF3A EXOC7 | 3.76e-06 | 647 | 169 | 14 | 26618866 |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 9020138 | ||
| Pubmed | 4.31e-06 | 397 | 169 | 11 | 21319273 | ||
| Pubmed | 5.03e-06 | 327 | 169 | 10 | 31409639 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 5.03e-06 | 327 | 169 | 10 | 15592455 | |
| Pubmed | 5.30e-06 | 24 | 169 | 4 | 20624904 | ||
| Pubmed | DOCK2 RC3H1 SMC1A PLEKHA6 USP37 USP20 MYOF PER3 EIF5B CCT8 EIF3A EXOC7 | 5.87e-06 | 493 | 169 | 12 | 15368895 | |
| Pubmed | Huntingtin interacting proteins are genetic modifiers of neurodegeneration. | 5.89e-06 | 197 | 169 | 8 | 17500595 | |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 11309420 | ||
| Pubmed | 6.28e-06 | 25 | 169 | 4 | 20696915 | ||
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 6.66e-06 | 54 | 169 | 5 | 25631074 | |
| Pubmed | 6.73e-06 | 266 | 169 | 9 | 19380743 | ||
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 6.78e-06 | 143 | 169 | 7 | 30397336 | |
| Pubmed | CALU SPTAN1 UGGT1 CHCHD6 POF1B ERLEC1 CSE1L EIF5B EIF3A HBB PLOD1 | 7.01e-06 | 418 | 169 | 11 | 35338135 | |
| Pubmed | NOL4 TRAF5 NEBL LAMA2 GBE1 ERBIN ERLEC1 NME8 MIA2 RASSF6 XPNPEP3 DLG1 POLN IQUB | 7.30e-06 | 686 | 169 | 14 | 29987050 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PIK3R3 MAU2 TEX14 HRNR ASAP1 MIA2 XIRP2 PIK3R1 KDR ZMYM1 DNMT3B | 9.14e-06 | 430 | 169 | 11 | 35044719 |
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 12619131 | ||
| Pubmed | Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. | 9.27e-06 | 9 | 169 | 3 | 23853600 | |
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 20018779 | ||
| Pubmed | 9.68e-06 | 151 | 169 | 7 | 17043677 | ||
| Pubmed | 1.01e-05 | 28 | 169 | 4 | 18067320 | ||
| Pubmed | SMC1A RTN4 SMC4 CC2D1A ERBIN PRUNE1 CSDE1 UBA1 CSE1L EIF5B CCT8 DLG1 STIP1 PACSIN2 | 1.04e-05 | 708 | 169 | 14 | 39231216 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SEMG2 CALU RTN4 UGGT1 SMC4 MCCC1 ERBIN IFIT1 ASAP1 CSDE1 MYOF UBA1 H1-0 EIF5B OSBPL10 CCT8 DLG1 STIP1 EIF3A PLOD1 | 1.19e-05 | 1367 | 169 | 20 | 32687490 |
| Pubmed | DCAF1 OFD1 CALU SYNE1 SPTAN1 RTN4 UGGT1 PIK3R3 CHCHD6 CC2D1A ERBIN PTPN14 AKAP9 PIK3R1 EHMT1 EIF5B DLG1 STIP1 PLOD1 AQR PACSIN2 | 1.20e-05 | 1487 | 169 | 21 | 33957083 | |
| Pubmed | SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis. | 1.32e-05 | 10 | 169 | 3 | 14729577 | |
| Pubmed | Isolation of tyrosine kinase related genes expressed in the early hematopoietic system. | 1.32e-05 | 10 | 169 | 3 | 8034026 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.32e-05 | 10 | 169 | 3 | 22159418 | |
| Pubmed | Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. | 1.32e-05 | 10 | 169 | 3 | 10529424 | |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 20124353 | ||
| Pubmed | NUSAP1 ERCC6 NEBL SYNE1 SMC4 SPECC1L ERBIN CSDE1 TAF6L MYOF NUP37 EHMT1 EIF5B CCT8 DLG1 SCAF11 RBM8A STIP1 EIF3A DCLK1 AQR | 1.33e-05 | 1497 | 169 | 21 | 31527615 | |
| Pubmed | 1.53e-05 | 31 | 169 | 4 | 15638726 | ||
| Pubmed | TET2 TNPO2 SYNE1 SMC1A SPTAN1 PEG3 KRIT1 SPTBN4 CSDE1 MIA2 OTOF PIK3R1 DLG1 N4BP2L2 DLG4 TNKS2 EXOC7 DCLK1 PICK1 | 1.72e-05 | 1285 | 169 | 19 | 35914814 | |
| Pubmed | 1.74e-05 | 32 | 169 | 4 | 23986795 | ||
| Pubmed | SPTAN1 RTN4 RTN1 UBA1 CSE1L CCT8 DLG4 STIP1 DMD HBB HBD PACSIN2 | 1.81e-05 | 552 | 169 | 12 | 36293380 | |
| Pubmed | CALU SPTAN1 RTN4 UGGT1 SMC4 GBE1 ERLEC1 CSDE1 MYOF UBA1 FTH1 EHMT1 EIF5B CCT8 TMEM192 STIP1 EIF3A PLOD1 AQR | 1.96e-05 | 1297 | 169 | 19 | 33545068 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | NEBL CAMK2B SPTAN1 RTN4 RTN1 EIF5B CCT8 DLG1 STIP1 EIF3A DCLK1 PACSIN2 | 2.01e-05 | 558 | 169 | 12 | 35063084 |
| Pubmed | Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. | 2.08e-05 | 68 | 169 | 5 | 25754235 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CALU CAMK2B SYNE1 SMC1A SPTAN1 RTN4 UGGT1 SMC4 UBA1 CSE1L NF1 RPTOR PRIM1 H1-0 EHMT1 EIF5B CCT8 STIP1 EIF3A AQR | 2.15e-05 | 1425 | 169 | 20 | 30948266 |
| Pubmed | alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus. | 2.23e-05 | 34 | 169 | 4 | 16889989 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | NEBL SPTAN1 RTN4 CC2D1A PLEKHA6 ERBIN POF1B ASAP1 FTH1 CCT8 DLG1 PACSIN2 | 2.27e-05 | 565 | 169 | 12 | 25468996 |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12628756 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10753064 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 31443490 | ||
| Pubmed | flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. | 2.35e-05 | 2 | 169 | 2 | 8223275 | |
| Pubmed | Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. | 2.35e-05 | 2 | 169 | 2 | 21099112 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 20154719 | ||
| Pubmed | Ganglioside GM1 mediates decapacitation effects of SVS2 on murine spermatozoa. | 2.35e-05 | 2 | 169 | 2 | 18753612 | |
| Pubmed | Increased cation permeability in mutant mouse red blood cells with defective membrane skeletons. | 2.35e-05 | 2 | 169 | 2 | 7492791 | |
| Interaction | GRIN2B interactions | CAMK2B CAMK2G SPTA1 SPTAN1 ACTN2 ERBIN PTK2B NF1 AKAP9 PIK3R1 DLG1 DLG4 EXOC7 | 1.75e-09 | 170 | 167 | 13 | int:GRIN2B |
| Interaction | KCTD13 interactions | SLC12A6 CAMK2B SYNE1 CAMK2G SPTA1 TTC21A SPTAN1 RTN4 ACTN2 SPECC1L PLEKHA6 ERBIN RTN1 ASAP1 SPTBN4 CSDE1 PTK2B UBA1 CSE1L NF1 SRGAP3 RPTOR H1-0 FTH1 OSBPL10 CCT8 DLG1 DLG4 STIP1 EIF3A DMD HCK DCLK1 | 3.61e-08 | 1394 | 167 | 33 | int:KCTD13 |
| Interaction | GRIN1 interactions | CAMK2B CAMK2G SPTA1 SPTAN1 ACTN2 PTK2B NF1 AKAP9 PIK3R1 DLG1 DLG4 | 6.57e-08 | 154 | 167 | 11 | int:GRIN1 |
| Interaction | AGAP2 interactions | CAMK2B SYNE1 CAMK2G SPTAN1 ASAP1 PTK2B NF1 SRGAP3 PIK3R1 DLG1 DLG4 DCLK1 | 1.91e-07 | 210 | 167 | 12 | int:AGAP2 |
| Interaction | ZNF550 interactions | 1.10e-06 | 65 | 167 | 7 | int:ZNF550 | |
| Interaction | SHANK3 interactions | CAMK2B SYNE1 CAMK2G SPTAN1 RTN4 ACTN2 SPTBN4 UBA1 NF1 XIRP2 CCT8 DLG1 DLG4 EXOC7 DCLK1 PICK1 | 3.91e-06 | 496 | 167 | 16 | int:SHANK3 |
| Interaction | DNM2 interactions | OFD1 SMC1A GBE1 LCK TMEM9B ASAP1 PIK3R1 KDR STIP1 PLOD1 HCK PACSIN2 | 5.29e-06 | 288 | 167 | 12 | int:DNM2 |
| Interaction | TIMD4 interactions | 5.78e-06 | 15 | 167 | 4 | int:TIMD4 | |
| Interaction | CBL interactions | SPTA1 SPTAN1 PIK3R3 IRF8 LCK TEK ERBIN ASAP1 PTK2B PIK3R1 EIF5B CCT8 DLG1 KDR PLOD1 HCK | 6.44e-06 | 516 | 167 | 16 | int:CBL |
| Interaction | PTEN interactions | CAMK2G SPTA1 SPTAN1 UGGT1 SMC4 MCCC1 POF1B PTK2B MYOF UBA1 PTPN14 CASD1 NF1 PIK3R1 RPTOR H1-0 CCT8 DLG1 STIP1 TNKS2 HBB PICK1 | 9.02e-06 | 929 | 167 | 22 | int:PTEN |
| Interaction | ITGB3 interactions | 1.25e-05 | 170 | 167 | 9 | int:ITGB3 | |
| Interaction | KALRN interactions | 1.52e-05 | 96 | 167 | 7 | int:KALRN | |
| Interaction | PTPRE interactions | 2.30e-05 | 69 | 167 | 6 | int:PTPRE | |
| Interaction | DLG4 interactions | TNPO2 CAMK2B SYNE1 RTN4 ACTN2 ERBIN FAM81A PTK2B UBA1 PTPRG FTH1 DLG1 DLG4 PICK1 | 2.35e-05 | 449 | 167 | 14 | int:DLG4 |
| Interaction | FASLG interactions | 2.72e-05 | 105 | 167 | 7 | int:FASLG | |
| Interaction | GDA interactions | 2.94e-05 | 72 | 167 | 6 | int:GDA | |
| Interaction | TRPV4 interactions | 2.96e-05 | 22 | 167 | 4 | int:TRPV4 | |
| Interaction | TIAM1 interactions | 5.48e-05 | 205 | 167 | 9 | int:TIAM1 | |
| Interaction | TSC1 interactions | CAMK2B CAMK2G ACTN2 TEX14 RPTOR ZNF587 FTH1 CCT8 DLG4 EIF3A ZNF417 PICK1 | 5.66e-05 | 366 | 167 | 12 | int:TSC1 |
| Interaction | DISC1 interactions | OFD1 SYNE1 SPTAN1 PIK3R3 ACTN2 SPECC1L SPTBN4 AKAP9 SRGAP3 DLG1 DMD TNKS2 EXOC7 | 6.19e-05 | 429 | 167 | 13 | int:DISC1 |
| Interaction | KHDRBS1 interactions | DOCK2 ERCC6 TNPO2 PIK3R3 LCK MIA2 PIK3R1 DLG1 DLG4 STIP1 HCK PACSIN2 | 6.78e-05 | 373 | 167 | 12 | int:KHDRBS1 |
| Interaction | YES1 interactions | CAMK2G PIK3R3 LCK POF1B ERLEC1 PIK3R1 FTH1 DLG4 KDR STIP1 HCK PICK1 | 7.14e-05 | 375 | 167 | 12 | int:YES1 |
| Interaction | RHOQ interactions | SPTAN1 PIK3R3 CC2D1A ERBIN MYOF NF1 PTPRG PIK3R1 RPTOR DLG1 EXOC7 ZNF417 PACSIN2 | 8.37e-05 | 442 | 167 | 13 | int:RHOQ |
| Interaction | H2BC9 interactions | ABCA13 SMC1A SPTAN1 LAMA2 CC2D1A SPECC1L TEX15 LCK NEB OTOF XIRP2 H1-0 STIP1 | 9.16e-05 | 446 | 167 | 13 | int:H2BC9 |
| Interaction | AGR2 interactions | DOCK2 SYNE1 SPTA1 SPTAN1 RTN4 UGGT1 MCCC1 USP20 MYOF CSE1L AKAP9 H1-0 SCN8A EIF5B CCT8 RBM8A STIP1 EIF3A HBB HCK | 9.64e-05 | 934 | 167 | 20 | int:AGR2 |
| Interaction | YWHAG interactions | TET2 CAMK2G RC3H1 SPTAN1 SPECC1L USP37 ERBIN UBA1 PTPN14 CSE1L NF1 AKAP9 RHPN2 PIK3R1 RPTOR PRIM1 OSBPL10 DLG4 KDR SCAF11 STIP1 PPIP5K2 DCLK1 AQR | 9.98e-05 | 1248 | 167 | 24 | int:YWHAG |
| Interaction | KCNA3 interactions | ABCA13 SMC1A RTN4 SMC4 CC2D1A SPECC1L ERBIN PRUNE1 CSDE1 TAF6L UBA1 CSE1L RPTOR EIF5B CCT8 DLG1 DLG4 STIP1 PACSIN2 | 1.15e-04 | 871 | 167 | 19 | int:KCNA3 |
| Interaction | SLC9A2 interactions | 1.16e-04 | 12 | 167 | 3 | int:SLC9A2 | |
| Interaction | EPHA7 interactions | ZNF267 ERBIN VWDE MANSC1 PIK3R1 WNT16 DLG1 PLOD1 PACSIN2 PICK1 | 1.26e-04 | 282 | 167 | 10 | int:EPHA7 |
| Interaction | DOK1 interactions | 1.28e-04 | 59 | 167 | 5 | int:DOK1 | |
| Interaction | LCK interactions | CAMK2G SPTAN1 PLEKHA6 LCK ERBIN PTK2B PTPN14 NF1 PIK3R1 CCT8 DLG1 STIP1 HCK | 1.33e-04 | 463 | 167 | 13 | int:LCK |
| Interaction | ERBB4 interactions | 1.53e-04 | 184 | 167 | 8 | int:ERBB4 | |
| Interaction | KIF13B interactions | 1.84e-04 | 142 | 167 | 7 | int:KIF13B | |
| Interaction | CFTR interactions | SEMG2 TIMD4 CALU SPTAN1 UGGT1 SMC4 ACTN2 SPECC1L PLEKHA6 MCCC1 HRNR ERBIN POF1B UBA1 CSE1L XPNPEP3 FTH1 CCT8 DLG1 EIF3A DMD EXOC7 HBB HBD DCLK1 IQUB | 2.14e-04 | 1480 | 167 | 26 | int:CFTR |
| Interaction | USP7 interactions | TET2 TRAF5 ERCC6 ANK1 OFD1 SYNE1 SPTAN1 PEG3 VSTM2A LCA5L RFFL TEX15 LCK HRNR NEB GJB3 OTOF IKBKE EHMT1 KDR STIP1 ZMYM1 DMD PICK1 | 2.15e-04 | 1313 | 167 | 24 | int:USP7 |
| Interaction | CNKSR2 interactions | 2.19e-04 | 66 | 167 | 5 | int:CNKSR2 | |
| GeneFamily | EF-hand domain containing|Spectrins | 8.17e-06 | 7 | 113 | 3 | 1113 | |
| GeneFamily | Ferlin family | 5.71e-04 | 6 | 113 | 2 | 828 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 7.97e-04 | 7 | 113 | 2 | 761 | |
| GeneFamily | Hemoglobin subunits | 1.69e-03 | 10 | 113 | 2 | 940 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF143 PEG3 ZNF267 ZNF883 ZNF676 ZNF587 ZNF408 ZNF737 ZNF534 ZNF721 ZNF417 ZNF726 | 1.77e-03 | 718 | 113 | 12 | 28 |
| GeneFamily | PDZ domain containing | 2.66e-03 | 152 | 113 | 5 | 1220 | |
| GeneFamily | SH2 domain containing | 3.71e-03 | 101 | 113 | 4 | 741 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.76e-03 | 50 | 113 | 3 | 1293 | |
| GeneFamily | Ankyrin repeat domain containing | 4.15e-03 | 242 | 113 | 6 | 403 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 9.17e-07 | 158 | 169 | 9 | M372 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 1.84e-06 | 32 | 169 | 5 | MM17 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 2.51e-06 | 34 | 169 | 5 | M45005 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | NUSAP1 EBF3 PIK3R3 PEG3 IFIT1 PER3 PIK3R1 PRIM1 IFIT1B DCLK1 | 1.12e-05 | 271 | 169 | 10 | MM1075 |
| Coexpression | FIRESTEIN_PROLIFERATION | 1.29e-05 | 166 | 169 | 8 | M5354 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP | 1.88e-05 | 175 | 169 | 8 | M8578 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBM | 2.32e-05 | 295 | 169 | 10 | M39063 | |
| Coexpression | GSE11057_PBMC_VS_MEM_CD4_TCELL_DN | 4.55e-05 | 198 | 169 | 8 | M3121 | |
| Coexpression | GSE3982_BCELL_VS_BASOPHIL_UP | 4.71e-05 | 199 | 169 | 8 | M5538 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 4.79e-05 | 258 | 169 | 9 | M2446 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 4.88e-05 | 200 | 169 | 8 | M4512 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | SPATA7 BRINP3 TRAF5 NEBL CAMK2B NAIP RTN1 CASD1 NF1 GPC3 ZNF587 N4BP2L2 EXOC7 DCLK1 AQR | 5.04e-05 | 699 | 169 | 15 | M4960 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 6.61e-05 | 269 | 169 | 9 | M41203 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.89e-08 | 170 | 169 | 9 | 74bb46826141bd1e80b4ce16e6bbfc770bd427d3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.89e-08 | 170 | 169 | 9 | 6592ebe204b43b81c6b6da99e05da72c0983b3fa | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-08 | 132 | 169 | 8 | a1f98d9245c8fe02ea3f098f04919a7d5fc6cbc7 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.72e-08 | 197 | 169 | 9 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.93e-07 | 170 | 169 | 8 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.72e-07 | 181 | 169 | 8 | 9dc0563453e24c9d1d975e2e0e1e272487e19908 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.72e-07 | 181 | 169 | 8 | c5843b89f3d362e236ff76c3279518a2fdfc1f75 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.72e-07 | 181 | 169 | 8 | 14c2dd946e89ba578711c2d25935b6b3d319b701 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.72e-07 | 181 | 169 | 8 | fcefb5902416c004631f4f8dd5c8f99fe3bd90bc | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-07 | 183 | 169 | 8 | f524501dec1dccbf44100a61395116e4525bdc89 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-07 | 186 | 169 | 8 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.04e-07 | 187 | 169 | 8 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 169 | 8 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 169 | 8 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.29e-07 | 188 | 169 | 8 | adf9011ba8e3c6418fb68bf5c44b2e3b0ec7dafe | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.82e-07 | 190 | 169 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-07 | 192 | 169 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.29e-07 | 195 | 169 | 8 | 75db19c0371320ea5fce1d6de8c1b40b1e6a2e58 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 8.61e-07 | 135 | 169 | 7 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.62e-07 | 196 | 169 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.95e-07 | 197 | 169 | 8 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-07 | 197 | 169 | 8 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-07 | 198 | 169 | 8 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-07 | 198 | 169 | 8 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.30e-07 | 198 | 169 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 199 | 169 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 9.66e-07 | 199 | 169 | 8 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-06 | 200 | 169 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 1.00e-06 | 200 | 169 | 8 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 1.00e-06 | 200 | 169 | 8 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 142 | 169 | 7 | 39ada235a46f2202c093cf2336de224a5957ed1a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-06 | 153 | 169 | 7 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-06 | 155 | 169 | 7 | a16e3a72badafa78a3efc4f4ab62396f0ce99d1e | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 158 | 169 | 7 | 9fd77ebdd1babf1c85a85d38d9a15858ab08bc84 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 158 | 169 | 7 | 0edd9b005875f9a4f5446f5d5161f8ba63860793 | |
| ToppCell | COVID-naiveBc|COVID / Condition, Cell_class and T cell subcluster | 2.57e-06 | 159 | 169 | 7 | 52cd36b4412f69a935b3f76da96c166a9481eb0c | |
| ToppCell | COVID-naiveBc-|COVID / Condition, Cell_class and T cell subcluster | 2.57e-06 | 159 | 169 | 7 | 4e6783b0f69c0c70150f9f3594881dc1bac7038a | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-06 | 162 | 169 | 7 | 25a11e4c6304324310b33a33331ebc812d045d4a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.29e-06 | 165 | 169 | 7 | ebd668e87e5961a124d1d6fc25d1f03e4af05cd4 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.70e-06 | 168 | 169 | 7 | 360cd756067c8cfb6a78301674758eb5fac52c23 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.70e-06 | 168 | 169 | 7 | d791116040a9d3ea0485d68c974340116073986b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.32e-06 | 172 | 169 | 7 | 9497948bbe53fb88c6ff6b347f743d456da587e5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-06 | 175 | 169 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-06 | 176 | 169 | 7 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 5.22e-06 | 177 | 169 | 7 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 178 | 169 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.62e-06 | 179 | 169 | 7 | 64672528f73ac0921f9c7df72e14ecbfac4d5270 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.62e-06 | 179 | 169 | 7 | dfefa4b7ae0ee50cf67e0f1938c682f08a03ec53 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-06 | 179 | 169 | 7 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.62e-06 | 179 | 169 | 7 | fa0dd87111d399649cdea55f2e610ebc169e8a56 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-06 | 180 | 169 | 7 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-06 | 181 | 169 | 7 | f4cd6dba4c04c5cb550f44468eb29c07238fbda4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-06 | 181 | 169 | 7 | c7f5d0e5aa2ca6a409957713637e1b37a73ceb60 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.50e-06 | 183 | 169 | 7 | b52d7683dc6652766e814ebe935c264ecd610c4b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.50e-06 | 183 | 169 | 7 | 1d77d8d8c8f78f43dd8864e76f294ee66d4942c2 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.50e-06 | 183 | 169 | 7 | 1db466cf757813322db1cdcc0bf1d91c062fd9de | |
| ToppCell | wk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.50e-06 | 183 | 169 | 7 | 7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 6.97e-06 | 185 | 169 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.22e-06 | 186 | 169 | 7 | 3b60a153e6cfc1b977a1f8b8f3bcaf75d1f4ff5b | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.22e-06 | 186 | 169 | 7 | 6078aa16261554c7fd41137b8de1362d15b30490 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-06 | 188 | 169 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.75e-06 | 188 | 169 | 7 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.02e-06 | 189 | 169 | 7 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 8.02e-06 | 189 | 169 | 7 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.02e-06 | 189 | 169 | 7 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.30e-06 | 190 | 169 | 7 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.30e-06 | 190 | 169 | 7 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.30e-06 | 190 | 169 | 7 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 8.30e-06 | 190 | 169 | 7 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-06 | 191 | 169 | 7 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | Bronchial-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.72e-06 | 126 | 169 | 6 | b6482ef18e6d9e12ba4810ce7845f9f991cb95bc | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.72e-06 | 126 | 169 | 6 | 65c7c0e4cfb5ac58d80b4034d42e9f662116e0d3 | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.72e-06 | 126 | 169 | 6 | 12f3d0f60db462f2a9799b3a06005bc871670760 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-06 | 192 | 169 | 7 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 9.19e-06 | 193 | 169 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.19e-06 | 193 | 169 | 7 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.51e-06 | 194 | 169 | 7 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-06 | 194 | 169 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 9.83e-06 | 195 | 169 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.83e-06 | 195 | 169 | 7 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.83e-06 | 195 | 169 | 7 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.02e-05 | 196 | 169 | 7 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-05 | 196 | 169 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 196 | 169 | 7 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | erythropoietic-Erythrocyte|World / Lineage and Cell class | 1.02e-05 | 196 | 169 | 7 | 1642d9340f621cd55987ef8154b48aa306f0f0c8 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.05e-05 | 197 | 169 | 7 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 197 | 169 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 197 | 169 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 197 | 169 | 7 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.05e-05 | 197 | 169 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| Drug | HPED | 1.54e-06 | 4 | 167 | 3 | CID000125856 | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.04e-06 | 197 | 167 | 10 | 3351_UP | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | 2.04e-06 | 197 | 167 | 10 | 7069_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A | 2.34e-06 | 200 | 167 | 10 | 3078_DN | |
| Drug | dimethyl adipimidate | 2.46e-06 | 30 | 167 | 5 | CID000025738 | |
| Drug | HBED | 4.74e-06 | 16 | 167 | 4 | CID000037336 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.12e-05 | 189 | 167 | 9 | 5248_DN | |
| Drug | AC1L1KMJ | ANK1 SPTA1 SPTAN1 PIK3R3 PEG3 LAMA2 LCK SPTBN4 PTK2B CSE1L GRK3 PIK3R1 DLG4 HCK | 1.18e-05 | 476 | 167 | 14 | CID000030956 |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.27e-05 | 192 | 167 | 9 | 2865_DN | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.44e-05 | 195 | 167 | 9 | 6224_UP | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.44e-05 | 195 | 167 | 9 | 7468_UP | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.50e-05 | 196 | 167 | 9 | 1531_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.56e-05 | 197 | 167 | 9 | 5949_UP | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.56e-05 | 197 | 167 | 9 | 7474_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.63e-05 | 198 | 167 | 9 | 6635_UP | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A | 1.63e-05 | 198 | 167 | 9 | 4698_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.69e-05 | 199 | 167 | 9 | 6477_DN | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.76e-05 | 200 | 167 | 9 | 5432_UP | |
| Drug | AC1L252K | 3.15e-05 | 9 | 167 | 3 | CID000015061 | |
| Drug | spermine | SPTA1 SPTAN1 PIK3R3 XDH SPTBN4 TGM4 PIK3R1 PRIM1 H1-0 HBB HBD OAZ3 | 3.60e-05 | 394 | 167 | 12 | CID000001103 |
| Drug | saracatinib | 4.30e-05 | 27 | 167 | 4 | CID010302451 | |
| Drug | Linuron | 4.52e-05 | 128 | 167 | 7 | ctd:D008044 | |
| Drug | epoxiconazole | DPP10 NEBL CAMK2B CAMK2G NF1 AKAP9 IKBKE DLG1 DLG4 TNKS2 PRG4 | 4.58e-05 | 341 | 167 | 11 | ctd:C109476 |
| Drug | 32 P | CAMK2B SPTA1 SPTAN1 LCK KRIT1 SPTBN4 GRK3 PRIM1 H1-0 POLN HBB HBD | 4.70e-05 | 405 | 167 | 12 | CID000448772 |
| Drug | tricapryl(methyl)ammonium | 5.35e-05 | 2 | 167 | 2 | CID011071504 | |
| Drug | allyl 2,4,6-tribromophenyl ether | 5.35e-05 | 2 | 167 | 2 | CID000076767 | |
| Drug | 1,3,5-tribromobenzene | 5.35e-05 | 2 | 167 | 2 | CID000012279 | |
| Drug | 2-(alpha-hydroxybenzyl)-benzimidazole | 5.35e-05 | 2 | 167 | 2 | CID000005792 | |
| Drug | NSC-334295 | 5.35e-05 | 2 | 167 | 2 | CID000100107 | |
| Drug | AC1L3OJQ | 5.35e-05 | 2 | 167 | 2 | CID000119294 | |
| Drug | pentabromobenzene | 5.35e-05 | 2 | 167 | 2 | CID000011854 | |
| Drug | tribromobenzene | 5.35e-05 | 2 | 167 | 2 | CID000011842 | |
| Drug | Bromkal 73-5 PE | 5.35e-05 | 2 | 167 | 2 | CID000118216 | |
| Drug | Methylmercury Compounds | SOX5 CALU PEG3 SMC4 RTN1 GSTA4 ZNF676 PER3 PIK3R1 H1-0 FTH1 CCT8 DLG4 KDR TNKS2 CNTF DNMT3B NCKAP1L | 5.62e-05 | 851 | 167 | 18 | ctd:D008767 |
| Drug | cnicin | 6.03e-05 | 92 | 167 | 6 | CID000091176 | |
| Drug | Methylcholanthrene | NUSAP1 ERCC6 ABI3BP CAMK2B XDH RFFL PLEKHA6 IFIT1 RTN1 MYOF CD3G PIK3R1 ZNF587 FTH1 OSBPL10 CCT8 STIP1 PRG4 HCK DCLK1 | 7.39e-05 | 1034 | 167 | 20 | ctd:D008748 |
| Drug | 3-methacryloxypropyltrimethoxysilane | 8.12e-05 | 12 | 167 | 3 | CID000017318 | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 8.93e-05 | 192 | 167 | 8 | 2766_DN | |
| Drug | selenocystein | 9.12e-05 | 143 | 167 | 7 | CID006326972 | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 9.26e-05 | 193 | 167 | 8 | 2294_DN | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.26e-05 | 193 | 167 | 8 | 6587_UP | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A | 9.26e-05 | 193 | 167 | 8 | 2505_DN | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 9.59e-05 | 194 | 167 | 8 | 3875_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; PC3; HT_HG-U133A | 9.59e-05 | 194 | 167 | 8 | 5076_DN | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 9.59e-05 | 194 | 167 | 8 | 6066_UP | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 9.59e-05 | 194 | 167 | 8 | 4662_DN | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 9.94e-05 | 195 | 167 | 8 | 4577_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.94e-05 | 195 | 167 | 8 | 6868_DN | |
| Drug | Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 9.94e-05 | 195 | 167 | 8 | 7198_DN | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.94e-05 | 195 | 167 | 8 | 6650_DN | |
| Drug | 2,4,4'-trichlorobiphenyl | NUSAP1 NOL4 BRINP3 DPP10 ANK1 EBF3 ABCA13 CAMK2B SPTA1 SMC4 RFFL EBF1 PLEKHA6 GSTA4 PTK2B ATP6V1G3 GRK3 AKAP9 NUP37 PRIM1 DLG4 KDR DMD DNMT3B | 1.02e-04 | 1411 | 167 | 24 | ctd:C081766 |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 5279_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 5069_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 4840_DN | |
| Drug | ADPribulose | 1.05e-04 | 13 | 167 | 3 | CID000197570 | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 3127_DN | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 4836_DN | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 5666_DN | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 6597_DN | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 6487_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 4077_UP | |
| Drug | raloxifene hydrochloride; Up 200; 0.1uM; MCF7; HG-U133A | 1.07e-04 | 197 | 167 | 8 | 202_UP | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 3081_DN | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 6248_UP | |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 5864_DN | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 4428_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 5495_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 2348_DN | |
| Drug | Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 6461_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 7016_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 6775_UP | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 4795_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.18e-04 | 200 | 167 | 8 | 2453_DN | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | NUSAP1 NOL4 BRINP3 DPP10 ANK1 EBF3 ABCA13 CAMK2B SPTA1 SMC4 RFFL EBF1 PLEKHA6 GSTA4 PTK2B ATP6V1G3 GRK3 AKAP9 NUP37 PRIM1 DLG4 KDR DMD DNMT3B | 1.40e-04 | 1441 | 167 | 24 | ctd:C009828 |
| Drug | ponatinib | 1.44e-04 | 68 | 167 | 5 | ctd:C545373 | |
| Drug | furyl-dihydropyridine I | 1.60e-04 | 3 | 167 | 2 | CID000125806 | |
| Drug | skyrin | 1.60e-04 | 3 | 167 | 2 | CID000073071 | |
| Drug | pentabromoethylbenzene | 1.60e-04 | 3 | 167 | 2 | CID000006800 | |
| Drug | Nx-D | 1.60e-04 | 3 | 167 | 2 | CID006914638 | |
| Drug | rhenanite | 1.60e-04 | 3 | 167 | 2 | CID000166906 | |
| Drug | mer13 | 1.60e-04 | 3 | 167 | 2 | CID000107453 | |
| Drug | BTBPE | 1.60e-04 | 3 | 167 | 2 | CID000037840 | |
| Drug | PRODAN | 1.65e-04 | 15 | 167 | 3 | CID000028127 | |
| Drug | NSC618487 | SLC12A6 ANK1 CAMK2B CAMK2G PIK3R3 LCK TEK KRIT1 PTK2B CSE1L GRK3 PIK3R1 H1-0 KDR TNKS2 ZBED1 HCK CNTF | 1.78e-04 | 933 | 167 | 18 | CID000005279 |
| Drug | Gm(5')ppp | 2.02e-04 | 16 | 167 | 3 | CID000173813 | |
| Drug | Melphalan | 2.10e-04 | 276 | 167 | 9 | ctd:D008558 | |
| Drug | thiobarbituric acid | 2.38e-04 | 118 | 167 | 6 | CID002723628 | |
| Drug | ApUpG | 2.44e-04 | 17 | 167 | 3 | CID000165128 | |
| Drug | ampicillinoic acid | 2.51e-04 | 42 | 167 | 4 | CID006453491 | |
| Drug | Glu-Lys | 2.76e-04 | 43 | 167 | 4 | CID005288444 | |
| Drug | Src family kinase inhibitor PP2 | 2.92e-04 | 18 | 167 | 3 | CID000004878 | |
| Drug | sitagliptin | 3.02e-04 | 44 | 167 | 4 | CID004369359 | |
| Drug | 4-(2-carboxyvinyl)benzoic acid | 3.18e-04 | 4 | 167 | 2 | CID000089196 | |
| Drug | 1,4-dibromobenzene | 3.18e-04 | 4 | 167 | 2 | CID000007804 | |
| Drug | Iron Dextran | 3.18e-04 | 4 | 167 | 2 | DB00893 | |
| Drug | AC1L4CDO | 3.18e-04 | 4 | 167 | 2 | CID000154482 | |
| Drug | PTU-23 | 3.18e-04 | 4 | 167 | 2 | CID000853760 | |
| Drug | AC1L9JVG | 3.18e-04 | 4 | 167 | 2 | CID000446603 | |
| Drug | 1,2,4,5-tetrabromobenzene | 3.18e-04 | 4 | 167 | 2 | CID000012486 | |
| Drug | I11-0029 | 3.29e-04 | 45 | 167 | 4 | CID005251896 | |
| Disease | Malignant neoplasm of breast | ERCC6 ANK1 SYNE1 SPTAN1 IRF8 SUSD3 LAMA2 XDH TEK NME8 PTPN14 NF1 MIA2 AKAP9 PER3 OTOF SRGAP3 EHMT1 KDR DMD PLOD1 DNMT3B | 1.02e-07 | 1074 | 161 | 22 | C0006142 |
| Disease | Colorectal Carcinoma | NUSAP1 TET2 ERCC6 ABCA13 SYNE1 RTN4 PEG3 CSE1L NF1 AKAP9 RHPN2 WNT16 KDR DMD DCLK1 IQUB | 1.64e-06 | 702 | 161 | 16 | C0009402 |
| Disease | carcinoma (implicated_via_orthology) | 2.67e-05 | 64 | 161 | 5 | DOID:305 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.91e-05 | 108 | 161 | 6 | DOID:684 (biomarker_via_orthology) | |
| Disease | Simpson-Golabi-Behmel syndrome | 8.84e-05 | 3 | 161 | 2 | cv:C4317043 | |
| Disease | Delta-Beta Thalassemia | 8.84e-05 | 3 | 161 | 2 | C0271985 | |
| Disease | beta thalassemia (implicated_via_orthology) | 8.84e-05 | 3 | 161 | 2 | DOID:12241 (implicated_via_orthology) | |
| Disease | hereditary spherocytosis type 1 (implicated_via_orthology) | 1.76e-04 | 4 | 161 | 2 | DOID:0110916 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia 12 (implicated_via_orthology) | 1.76e-04 | 4 | 161 | 2 | DOID:0110765 (implicated_via_orthology) | |
| Disease | hereditary spherocytosis (is_implicated_in) | 2.93e-04 | 5 | 161 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Cerebellar Ataxia | 2.93e-04 | 5 | 161 | 2 | C0007758 | |
| Disease | Hereditary spherocytosis | 2.93e-04 | 5 | 161 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 2.93e-04 | 5 | 161 | 2 | C0221409 | |
| Disease | hemoglobin measurement, hemoglobin A2 measurement | 2.93e-04 | 5 | 161 | 2 | EFO_0004509, EFO_0005845 | |
| Disease | Schizophrenia | SOX5 ABCA13 CAMK2B RTN4 LAMA2 PLEKHA6 SRGAP3 DLG1 DLG4 KDR DCLK1 CNTF PICK1 DNMT3B | 3.62e-04 | 883 | 161 | 14 | C0036341 |
| Disease | Pathologic Neovascularization | 4.37e-04 | 6 | 161 | 2 | C0027686 | |
| Disease | hemoglobin E disease | 4.37e-04 | 6 | 161 | 2 | MONDO_0016243 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 4.72e-04 | 28 | 161 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 5.81e-04 | 30 | 161 | 3 | DOID:14330 (biomarker_via_orthology) | |
| Disease | anemia (biomarker_via_orthology) | 6.10e-04 | 7 | 161 | 2 | DOID:2355 (biomarker_via_orthology) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 6.10e-04 | 7 | 161 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Dermatologic disorders | 7.68e-04 | 75 | 161 | 4 | C0037274 | |
| Disease | Muscular Dystrophy | 8.11e-04 | 8 | 161 | 2 | C0026850 | |
| Disease | Hereditary spherocytosis | 8.11e-04 | 8 | 161 | 2 | C0037889 | |
| Disease | benign neoplasm (implicated_via_orthology) | 8.11e-04 | 8 | 161 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Polycythemia Vera | 8.11e-04 | 8 | 161 | 2 | C0032463 | |
| Disease | Colorectal Neoplasms | 8.50e-04 | 277 | 161 | 7 | C0009404 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 9.18e-04 | 35 | 161 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | Autism Spectrum Disorders | 1.23e-03 | 85 | 161 | 4 | C1510586 | |
| Disease | Combined immunodeficiency | 1.46e-03 | 41 | 161 | 3 | C0494261 | |
| Disease | response to radiation, breast carcinoma | 1.58e-03 | 11 | 161 | 2 | EFO_0000305, GO_0009314 | |
| Disease | hypertension (biomarker_via_orthology) | 1.59e-03 | 227 | 161 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.71e-03 | 93 | 161 | 4 | C1535926 | |
| Disease | Familial dilated cardiomyopathy | 1.79e-03 | 44 | 161 | 3 | C0340427 | |
| Disease | hemolysis | 2.17e-03 | 47 | 161 | 3 | EFO_0009473 | |
| Disease | retinal vasculature measurement | 2.22e-03 | 517 | 161 | 9 | EFO_0010554 | |
| Disease | Major Depressive Disorder | 2.24e-03 | 243 | 161 | 6 | C1269683 | |
| Disease | acute myeloid leukemia (is_marker_for) | 2.44e-03 | 49 | 161 | 3 | DOID:9119 (is_marker_for) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.44e-03 | 49 | 161 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | lifestyle measurement, depressive symptom measurement | 2.66e-03 | 105 | 161 | 4 | EFO_0007006, EFO_0010724 | |
| Disease | lymphocyte count | DOCK2 TET2 ANK1 TIMD4 SPTA1 RTN4 EBF1 PLEKHA6 MCCC1 ERLEC1 ATP6V1G3 IKBKE PIK3R1 STIP1 PPIP5K2 HBB DNMT3B | 2.75e-03 | 1464 | 161 | 17 | EFO_0004587 |
| Disease | Dupuytren Contracture | 2.95e-03 | 108 | 161 | 4 | EFO_0004229 | |
| Disease | Unipolar Depression | 3.07e-03 | 259 | 161 | 6 | C0041696 | |
| Disease | Intellectual Disability | 3.27e-03 | 447 | 161 | 8 | C3714756 | |
| Disease | lymphocyte percentage of leukocytes | TET2 ANK1 SPTA1 PIK3R3 IRF8 EBF1 ERLEC1 ATP6V1G3 IKBKE DNMT3B | 3.67e-03 | 665 | 161 | 10 | EFO_0007993 |
| Disease | muscular dystrophy (is_implicated_in) | 3.81e-03 | 17 | 161 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Psychoses, Substance-Induced | 3.81e-03 | 17 | 161 | 2 | C0033941 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.81e-03 | 17 | 161 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | sleep duration | 3.85e-03 | 362 | 161 | 7 | EFO_0005271 | |
| Disease | Hemangiosarcoma | 4.27e-03 | 18 | 161 | 2 | C0018923 | |
| Disease | stroke, major depressive disorder | 4.76e-03 | 19 | 161 | 2 | EFO_0000712, MONDO_0002009 | |
| Disease | Arsenic Induced Polyneuropathy | 4.76e-03 | 62 | 161 | 3 | C0751852 | |
| Disease | Arsenic Encephalopathy | 4.76e-03 | 62 | 161 | 3 | C0751851 | |
| Disease | Arsenic Poisoning | 4.76e-03 | 62 | 161 | 3 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 4.76e-03 | 62 | 161 | 3 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 4.76e-03 | 62 | 161 | 3 | C0274862 | |
| Disease | Bipolar Disorder | 4.82e-03 | 477 | 161 | 8 | C0005586 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.98e-03 | 63 | 161 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Deaf Mutism | 5.27e-03 | 20 | 161 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 5.27e-03 | 20 | 161 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 5.27e-03 | 20 | 161 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 5.27e-03 | 20 | 161 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 5.27e-03 | 20 | 161 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 5.27e-03 | 20 | 161 | 2 | C0011052 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KQFVKHIGELYSNNQ | 831 | P23470 | |
| QTLGKIQELNGHYNK | 76 | Q96LB4 | |
| NLKLSINHKITEEGY | 1296 | Q13075 | |
| KKNTARAYHLQDDGT | 391 | Q96DZ1 | |
| KEETEHLENGNKYPN | 801 | Q96RT1 | |
| QQITENLIKKYGTHF | 121 | Q76B58 | |
| KDNLGIHYKQQIDGL | 656 | Q99996 | |
| RAKNKQLGHEEDYAL | 541 | P35626 | |
| LAQSIKGNHLVKVYD | 21 | P09693 | |
| INYKNNIDKLEGDHQ | 686 | P35609 | |
| VKHEGNIKYVNDVRN | 616 | Q9UBC3 | |
| LQHQADVNAKTKLGY | 721 | P16157 | |
| KDIQEHKFIEAGQYN | 771 | Q12959 | |
| SHYKVGENADSQIKL | 56 | P07305 | |
| HDRKGKVTCQNNYAV | 171 | Q49SQ1 | |
| EKQKVAELYSIHNSG | 586 | Q69YQ0 | |
| KEKDVNSVGNSIYHL | 1586 | Q86UQ4 | |
| DKINFVIDNNKHTGA | 156 | O75534 | |
| RHLVYESDQNKDGKL | 271 | O43852 | |
| ADKISILTTYNGQKH | 1221 | O60306 | |
| VNAQDYKGQTAIHEA | 271 | A6NGH8 | |
| HYNELGAKVTERKQQ | 1551 | P11532 | |
| QAEYDRLKQQHEHKG | 3521 | P11532 | |
| YKSENGHVIKLNIET | 96 | Q8N608 | |
| GNTLQVLNAYKSKLH | 251 | Q9H0I3 | |
| QYNQEASVLQKKGHK | 121 | Q7Z5Q5 | |
| LVDYIQNHSKKGADQ | 391 | Q5TC82 | |
| DKFAEYGEIKNIHLN | 91 | Q9Y5S9 | |
| QKNLHILYGETEDGK | 71 | Q6ZTQ3 | |
| KTTYEGLQHLNKEQQ | 151 | Q8TBF8 | |
| IAQHYEKINENKVQG | 31 | A0A1B0GVH7 | |
| EHSAQLKAQILGYKA | 516 | O75665 | |
| YDGINHVIVKQGKQT | 1016 | P0DP91 | |
| LHAYLQGNTQVSRKK | 336 | Q86TP1 | |
| QDKVTTLYKGSQLHD | 14231 | Q8WXI7 | |
| KGDIAHIYDIQTGNK | 1196 | Q9Y4B6 | |
| KSTEQGNHDQLKELY | 86 | Q9UMX2 | |
| GHKDQEEKRFSYQQL | 471 | Q6NUN7 | |
| TIHDSIQYVQKNAGK | 326 | P51654 | |
| LGYNEEQIHKLDKVN | 566 | Q14164 | |
| NLLVYEHQDGSKSLK | 516 | O15075 | |
| QFSHGQKEELAKVYN | 1146 | P56645 | |
| KHAGKQDYNQEVDAS | 41 | Q02556 | |
| QHGEYDTLNKAELKE | 21 | Q86YZ3 | |
| IEKDGYNNNIHCLTK | 1021 | P55160 | |
| ASAQLLAYKEKGHSQ | 191 | Q9H8J5 | |
| RHLKAIGKYENSQNN | 181 | O95447 | |
| DQNQGEVVKHYKIRN | 171 | P06239 | |
| YESKKHKQGFLNEEN | 566 | O00522 | |
| TELHQNLDGLKKNYN | 2056 | P24043 | |
| LQDKNEYKVLEGHTD | 111 | Q8NFH4 | |
| GYIKHEARKGNENQD | 41 | Q9BXS6 | |
| NIEAVGKKLHEYNTQ | 441 | P27986 | |
| GKKLHEYNTQFQEKS | 446 | P27986 | |
| QLNQYHKDVSKREGS | 481 | Q8WVV4 | |
| LNTNQKIYDQEKSHG | 1046 | Q9GZU2 | |
| QNLLKQYSQHGLDGK | 276 | Q9UPT5 | |
| HQNYTKALAGKLVET | 536 | Q02809 | |
| HQKSKGNSYDVEVVL | 131 | Q8IVV7 | |
| HNTVKLGAFQAQEKE | 91 | P49642 | |
| VQKHLDLSNVAGYKA | 251 | Q9UNF0 | |
| EDNIDAVGKKLQEYH | 171 | Q92569 | |
| THYLNEQVKAIKELG | 136 | P02794 | |
| ETKEQLYKLQDGNHL | 36 | O15217 | |
| QAYVSEKHEGNKIIA | 601 | Q04446 | |
| QGDTVKHYKIRTLDN | 191 | P08631 | |
| IKIHNGSSEALSQYK | 171 | Q96PB1 | |
| TSDYHGLAQQKVEKI | 536 | Q8NCX0 | |
| KADKERHGVAIYNFQ | 6 | Q92608 | |
| KEEQHQLAVTAYLKN | 546 | Q14152 | |
| ESYVKHQGLNKNINL | 36 | P26441 | |
| NLLAYVKHLKGQNEE | 56 | Q5T764 | |
| DYKLAALHAKQQGDT | 266 | Q6P1N0 | |
| KSVKAIYNSGQDHVQ | 76 | Q9ULH1 | |
| EKEANSEKTNNGIHY | 96 | Q9UH73 | |
| KDIQAHKFIEAGQYN | 591 | P78352 | |
| KDGKNNVAIAVTYNH | 556 | Q96RQ3 | |
| NLLAYVKHLKGQNEE | 56 | P09914 | |
| YSGKILKNNETLVQH | 176 | Q8NA54 | |
| NVLEKNSKRYQALGH | 46 | A6NC97 | |
| YQKVVAGVANALAHK | 131 | P02042 | |
| YQKVVAGVANALAHK | 131 | P68871 | |
| ISNKYDKQNIGHSVL | 2606 | Q8NDH2 | |
| DKQNIGHSVLKENAF | 2611 | Q8NDH2 | |
| EGVYTNHKGEKINVA | 441 | Q14289 | |
| EKEPNNEKTNNGIHY | 96 | Q9H4W6 | |
| DGYKVNSHIAKLQEL | 66 | Q8WUB2 | |
| RQKHGDQCAKLYDNA | 106 | O75712 | |
| DDGHKKARNAYLNNS | 106 | Q9UHW9 | |
| GYALAHTQEGEEKKQ | 286 | Q99590 | |
| QVTHYLDAGQVKSVK | 236 | Q9Y6X3 | |
| NNHLEAVKYLIKAGA | 816 | Q9H9B1 | |
| DEDQHKLYQQIKAGA | 216 | Q13555 | |
| LKGQQEDKQDTDVHY | 1766 | Q9HC10 | |
| SYQGQIISHEKKAHD | 1056 | Q96PC5 | |
| YKSVLQAVQKTDEGH | 641 | Q16799 | |
| ELVQKYSNSALGHVN | 1086 | Q9NQC3 | |
| QIDHYLGLANKNVKD | 1161 | Q9NQC3 | |
| VSNAQVKADGHKVYG | 346 | Q9Y6J9 | |
| DEDQHKLYQQIKAGA | 216 | Q13554 | |
| KYGIIENVNKHNFQA | 596 | A2RUB1 | |
| ETVQAAYLGLKHFNK | 156 | Q96L08 | |
| GLEYARNTAHQLKQK | 481 | P0C7P3 | |
| DSLEAQLHEYVKQGN | 21 | Q8IWB6 | |
| AKRTYEEGLKHEANN | 91 | P31948 | |
| KNHDNLLTGAQNEFK | 191 | Q8IZU3 | |
| HEELAQKIKGYQEQI | 5781 | Q8NF91 | |
| YKDQKGLQHLVSGAE | 286 | Q8WZ73 | |
| GVKRYEQEHAAIQDK | 86 | Q9BRQ6 | |
| KNQYEKHKEVEAAQG | 916 | O60841 | |
| KENNTGYINASHIKV | 956 | Q15678 | |
| DQQHGRKANKISYQS | 276 | P04279 | |
| DQEHGHKENKISYQS | 336 | Q02383 | |
| DLLSHEQKGRYKQES | 536 | Q02383 | |
| YQLNVKTGNHILKSE | 116 | P49221 | |
| KTGNHILKSEENILY | 121 | P49221 | |
| AQEAAKVGEVYQQLH | 311 | Q8IUC4 | |
| IDDHNSNGKNKYKNL | 321 | O94818 | |
| AYQDKGVLHNEVKVS | 1326 | Q92954 | |
| EAGILQYFVNEQSKH | 101 | Q9BXB5 | |
| QADLVKDNGHKYFLS | 506 | Q8N122 | |
| AHSVLENAKNAYIKD | 526 | O00463 | |
| VGKQQTYELRNDHQK | 1946 | A4UGR9 | |
| VQKHPGNEKEDSLQY | 711 | Q8N2E2 | |
| HTYKLNEQDTDKLLG | 521 | Q9Y2H5 | |
| EKQGDTIEYLKRHNA | 236 | Q8IY95 | |
| AYIQHNSKDAKLIDG | 61 | P52747 | |
| KLIASKANDHQGFYL | 736 | P55060 | |
| ELQEHKAQAYLKVNA | 136 | Q8TAG5 | |
| TNVDECNVHKEGYNK | 86 | Q8N7Q3 | |
| CNVHKEGYNKLNQSL | 91 | Q8N7Q3 | |
| ENSGHIYNKNISQKD | 51 | Q9NQ34 | |
| LKNIVHGASNAYEAK | 561 | Q8N427 | |
| YVNGSNLITKLQAKH | 446 | O43295 | |
| LEKAGQKLIDVNHYA | 631 | Q13813 | |
| YGKDLTNVQNLQKKH | 706 | Q13813 | |
| IGEKNYHCNNSEKTL | 211 | Q14586 | |
| SGLILKNNVKAHYQS | 66 | O14787 | |
| GKNLDDTAYLHQHQK | 126 | Q96SQ5 | |
| LSTNLNEYKKIHTGD | 416 | Q8TF20 | |
| KAYGTQRDLKEHQVV | 416 | Q9H9D4 | |
| GKNLDDTAYLHQHQK | 126 | Q8TAU3 | |
| NIYGCKHVEKSISDN | 141 | Q76KX8 | |
| EKIGQYLSSNRDHKA | 1516 | P21359 | |
| GSSEYKINNKVVQLH | 101 | Q14683 | |
| HIVNQNFKSYAGEKI | 86 | Q9NTJ3 | |
| ELYEKKANCIANHTG | 1036 | Q9UQD0 | |
| YKSKHSEGVIIQQVN | 496 | Q9P0W8 | |
| KKHLQLEQGVENYEE | 1661 | Q9H254 | |
| NLYKEGDLTHFNQKL | 946 | P47989 | |
| GHLLKDKYENSIQIS | 246 | Q9UBV4 | |
| AQEAAKVGEVYQQLH | 226 | A8MT19 | |
| NIQGKYQKHQSLEAE | 86 | P02549 | |
| TIRYKVQGKNEDQHV | 671 | Q02763 | |
| HTAKKAIEYLEQGIQ | 161 | Q8NDW8 | |
| KVVQGHRQLDSYKNG | 911 | P22314 | |
| EYLLQHGADVNAQDK | 696 | Q9H2K2 | |
| GKEDLAKLHSAIYQN | 481 | Q9Y2K6 | |
| DECKVHKEGYNGLNQ | 121 | A6NNF4 | |
| EKENKVSLVVHYNTG | 31 | Q86T82 | |
| NTLHYVKNNQLIKDG | 311 | Q9NQH7 | |
| QQLAVKQNEEGKFSH | 506 | P35711 | |
| SNHGKKALLYTAVNQ | 1226 | Q6PGP7 | |
| DQHGVVYITENKNKT | 131 | P35968 | |
| HQGIHSEEKSYQCKQ | 171 | P0CG24 | |
| IHGQAYDSTTNLKIK | 711 | Q5SVZ6 | |
| KYDVQHNGSLKLENT | 731 | O43314 | |
| IENIYGDKKQDSHTN | 496 | Q9BXT5 | |
| HGYDSKKQQELTAAV | 116 | O96006 | |
| KKVNGKIQSTYDQDH | 216 | Q7Z7G0 | |
| KLYAVHQEGNKNVGL | 466 | P50990 | |
| ILNEQEGKSANYHDK | 181 | Q6N021 | |
| EGKSANYHDKNIVLL | 186 | Q6N021 | |
| QEVKGEVTIHYNKLQ | 91 | Q9NRD5 | |
| SQKHTRLDYIGDSKN | 346 | Q96H15 | |
| HRQLISKSNAGKINY | 211 | Q9NYU2 | |
| DECKVHKRGYNGLNQ | 121 | O75373 | |
| DVRGHSYLQENKIKT | 61 | Q92802 | |
| IPGNEENKQKTDVHY | 1821 | Q9NZM1 | |
| KNTQVVSDAAYKGVH | 811 | O76041 | |
| QAVKSGKQLSDAVYH | 4901 | P20929 |